Oncolytics Biotech, Inc.

Twitter LinkedIn
  • Home
  • About
    • Our Company
    • Management Team
    • Board of Directors
  • Technology
    • What is Pelareorep?
    • What Does Pelareorep Do?
    • Delivery
    • Intellectual Property
    • Posters & Publications
    • Manufacturing
  • Clinical Trials
    • Clinical Development Plan
    • Collaborators
    • Pipeline
  • Media
    • Press Releases
    • Insights
  • Investors
    • Overview
    • Press Releases
    • Events & Presentations
    • Stock Information
    • Filings & Financials
    • Corporate Governance
    • FAQs
    • Email Alerts
    • IR Contacts
  • Contact
  • Careers

News

Media

Media

  • Press Releases
  • Insights
Apr 14, 2010

Oncolytics Biotech(R) Inc. Announces Reovirus Research to be Presented at AACR Annual Meeting

Apr 8, 2010

Oncolytics Biotech(R) Inc. Announces Publication of Preclinical Research on Combination of Antiangiogenic Cancer Therapy with Oncolytic Virotherapy

Apr 6, 2010

Media Advisory - Oncolytics Biotech(R) Inc. to Present at BioFinance 2010

Mar 30, 2010

Oncolytics Biotech(R) Inc. Announces Start of Enrolment in U.S. Phase 2 SCC Lung Cancer Trial

Mar 9, 2010

Oncolytics Biotech(R) Inc. Announces 2009 Year End Results

Feb 16, 2010

Oncolytics Biotech(R) Inc. Receives Approval from the U.K. MHRA to Conduct Phase 3 Trial for REOLYSIN(R) in Head and Neck Cancers

Feb 4, 2010

Media Advisory - Oncolytics Biotech(R) Inc. to Present at 12th Annual BIO CEO & Investor Conference

Jan 21, 2010

Media Advisory - Oncolytics Biotech(R) Inc. to Present at BioPartnering North America

Dec 11, 2009

Oncolytics Biotech(R) Inc. Appoints Senior Vice President, Global Licensing and Business Development

Dec 2, 2009

Oncolytics Biotech(R) Inc. Announces Exercise of Underwriters' Over-Allotment Option

    • 1...
    • 33
    • 34
    • 35
    • 36
    • 37
    • 38
    • 39
    • 40
    • 41
    • 42
    • ...53
    © 2021 Oncolytics Biotech, Inc. All Rights Reserved.
    Privacy Policy Disclaimer Sitemap